Company Filing History:
6 out of 1,248 
2 out of 47 
1 out of 121 
Years Active: 1998-2011
Title: Beate Diefenbach: Innovator in Biochemical Research
Introduction
Beate Diefenbach is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of biochemical research, particularly in the development of novel therapeutic compounds. With a total of 10 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
One of her latest patents involves a novel purified recombinant αβ-adhesion receptor. This invention showcases an unimpaired ligand binding activity and outlines a process for preparing the soluble non-membrane bound receptor using recombinant techniques. The receptor can serve as an effective screening tool for new therapeutic compounds that may inhibit the natural αβ-adhesion receptor. Additionally, her work includes the development of cyclopeptide derivatives, which can be utilized as integrin inhibitors for the prevention and treatment of circulatory diseases, thrombosis, and other related health issues.
Career Highlights
Throughout her career, Beate Diefenbach has worked with notable organizations, including Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent Gesellschaft mit. Her innovative research has positioned her as a key figure in her field, contributing to advancements in therapeutic solutions.
Collaborations
Beate has collaborated with esteemed colleagues such as Alfred Jonczyk and Horst Kessler. These partnerships have further enriched her research and development efforts.
Conclusion
Beate Diefenbach's contributions to biochemical research and her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for new therapeutic advancements that can significantly benefit healthcare.